RECRUITINGOBSERVATIONAL
Blood And Tears in Alzheimer's Disease
Examination of Alzheimer's Disease Biomarkers in Tears and Dry Blood Spots
About This Trial
This study aims to investigate whether biomarkers of Alzheimer's disease can be found in tearfluid, as well as dried bloodspots in patients with Alzheimer's disease, other dementia diagnoses compared to controls.
Who May Be Eligible (Plain English)
Who May Qualify:
Inclusion criteria for patients:
- Lumbar puncture with CSF avaiable for analysis
- Diagnosis of Alzheimer's disease, Dementia with Lewy Bodies (DLB), Frontotemporal dementia (FTD), vascular dementia (VaD) or Normal pressure hydrocephalus (NPH)
- Of legal age.
Inclusion criteria for controls:
- Lumbar puncture with CSF avaiable for analysis
- No neurological disease.
- Of legal age.
Who Should NOT Join This Trial:
- No lumbar puncture
- Clinically assessed as unfit to participate in the project.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
Inclusion criteria for patients:
* Lumbar puncture with CSF avaiable for analysis
* Diagnosis of Alzheimer's disease, Dementia with Lewy Bodies (DLB), Frontotemporal dementia (FTD), vascular dementia (VaD) or Normal pressure hydrocephalus (NPH)
* Of legal age.
Inclusion criteria for controls:
* Lumbar puncture with CSF avaiable for analysis
* No neurological disease.
* Of legal age.
Exclusion Criteria:
* No lumbar puncture
* Clinically assessed as unfit to participate in the project.
Locations (1)
Danish Dementia Research Centre
Copenhagen, Denmark